Effectiveness of Angelica and Astragliin proliferation inhibition and immunoregulation on non-small cell lung cancer
碩士 === 臺北醫學大學 === 醫學科學研究所 === 98 === Abstract Backgroud Lung cancer is the commonest malignant tumor in the world. The five-year survival rate of early stage, operable non-small cell lung cancer (NSCLC) patients was 60%, but there were approximately 70% of patients with NSCLC presenting with advanc...
| Main Authors: | , |
|---|---|
| Other Authors: | |
| Format: | Others |
| Language: | zh-TW |
| Published: |
2010
|
| Online Access: | http://ndltd.ncl.edu.tw/handle/41311051768677866897 |